Gland B2B Business Model and Growth Strategy
Generic Injectables: Growth Opportunity
US$131bn Market with Multiple Growth Levers Driven by LoEs, Opportunity from Shortages and Ease of Use
Sizeable Injectable Market ...
Injectable is a >US$400bn market
Growing Faster than Broader Market
with Robust Growth in Generics
Injectable recorded CAGR of 10.1% vs broader
market at 5.8%
Global Injectable Market
Global Pharma - Drug Delivery Mix
14-19
Key injectable markets like US, Europe and India
demonstrated double digit/high single digit growth
Geographic Mix- Generic Injectable
14-19
Global Pharma
826
1,096
CAGR
CAGR
Market Size
(US$bn)
131
(US$bn)
1,096
(US$bn)
6%
8%
32%
39%
826
174
3%
89
c.10% CAGR
432
147
1
432
267
10%
30
267
14
412
490
4%
18
2224
34
9%
20
3%
29
6%
10%
46
25
13%
2014
2019
2014
2014
2019
Oral Solids ■Injectable
Others
■North America
2019
Europe China
India
LOE Offering Significant Opportunity
Significant increase in value of injectable brand sales
scheduled to lose exclusivity
Loss of Exclusivity - Injectables
(US$bn)
33
61
2014-19
2019-24
Demand Driven by Drug Shortages
c.40-60% of US drug shortages are in injectables
Accessibility and Ease of Use
Convenience and benefits of New Drug Delivery
Systems driving growth across delivery formats
Global Injectable Market
14-19
(US$bn)
CAGR
(% Injectables
Share)
45% 45%
63% 58% 55% 39%
432
10%
66
10%
267
97
(#)
5%
42
84
102
57
61
101
77
131
78
15%
67
83
97
64
85
102
65
138
11%
81
2014
2015
2016
2017 2018
2019
2014
2019
20
20
■Injectables ■Non-Injectables
Source: IQVIA Report.
Note: MAT September 2014-2019. (1) Generic Injectable market share as a percentage of overall injectable market in the respective country.
Infusions Pre-filled Syringes Vials Others
GLANDView entire presentation